|
1
|
Pan Q, He C, Liu H, Liao X, Dai B, Chen Y,
Yang Y, Zhao B, Bihl J and Ma X: Microvascular endothelial
cells-derived microvesicles imply in ischemic stroke by modulating
astrocyte and blood brain barrier function and cerebral blood flow.
Mol Brain. 9:632016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu F, Li J, Ni W, Shen YW and Zhang XP:
Peroxisome proliferator-activated receptor-γ agonist
15d-prostaglandin J2 mediates neuronal autophagy after cerebral
ischemia-reperfusion injury. PLoS One. 8:e550802013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu JS, Tsai HD, Cheung WM, Hsu CY and Lin
TN: PPAR-γ ameliorates neuronal apoptosis and ischemic brain injury
via suppressing NF-κB-Driven p22phox transcription. Mol Neurobiol.
53:3626–3645. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Zhang X, Park TS and Gidday JM:
Cerebral endothelial cell apoptosis after ischemia-reperfusion:
Role of PARP activation and AIF translocation. J Cereb Blood Flow
Metab. 25:868–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fong WH, Tsai HD, Chen YC, Wu JS and Lin
TN: Anti-apoptotic actions of PPAR-gamma against ischemic stroke.
Mol Neurobiol. 41:180–186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ketsawatsomkron P and Sigmund CD:
Molecular mechanisms regulating vascular tone by peroxisme
proliferator activated receptor gamma. Curr Opin Nephrol Hyperten.
24:123–130. 2015. View Article : Google Scholar
|
|
7
|
Chu SF, Zhang Z, Zhang W, Zhang MJ, Gao Y,
Zuo W, Huang HY and Chen NH: Upregulating the expression of
survivin-HBXIP complex contributes to the protective role of
IMM-H004 in transient global cerebral ischemia/reperfusion. Mol
Neurobiol. 54:524–540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Jia S, Wang C, Chen Z, Chi Y, Li
J, Xu G, Guan Y and Yang J: FAM3A is a target gene of peroxisome
proliferator-activated receptor gamma. Biochim Biophysica Acta.
1830:4160–4170. 2013. View Article : Google Scholar
|
|
9
|
Romera C, Hurtado O, Mallolas J, Pereira
MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo
P, et al: Ischemic preconditioning reveals that GLT1/EAAT2
glutamate transporter is a novel PPARgamma target gene involved in
neuroprotection. J Cereb Blood Flow Metab. 27:1327–1338. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu JS, Cheung WM, Tsai YS, Chen YT, Fong
WH, Tsai HD, Chen YC, Liou JY, Shyue SK, Chen JJ, et al:
Ligand-activated peroxisome proliferator-activated receptor-gamma
protects against ischemic cerebral infarction and neuronal
apoptosis by 14-3-3 epsilon upregulation. Circulation.
119:1124–1134. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fukuda S and Pelus LM: Survivin, a cancer
target with an emerging role in normal adult tissues. Mol Cancer
Ther. 5:1087–1098. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Park TS and Gidday JM: Hypoxic
preconditioning protects human brain endothelium from ischemic
apoptosis by Akt-dependent survivin activation. Am J Physiol Heart
Circ Physiol. 292:H2573–H2581. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu M, Kwan T, Yu C, Chen F, Freedman B,
Schafer JM, Lee EJ, Jameson JL, Jordan VC and Cryns VL: Peroxisome
proliferator-activated receptor gamma agonists promote
TRAIL-induced apoptosis by reducing survivin levels via cyclin
D3 repression and cell cycle arrest. J Biol Chem.
280:6742–6751. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Tan H, Xu D, Ma A, Zhang L, Sun J,
Yang Z, Liu Y and Shi G: The combinatory effects of PPAR-γ agonist
and survivin inhibition on the cancer stem-like phenotype and cell
proliferation in bladder cancer cells. Int J Mol Med. 34:262–268.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamashita-Sugahara Y, Tokuzawa Y, Nakachi
Y, Kanesaki-Yatsuka Y, Matsumoto M, Mizuno Y and Okazaki Y: Fam57b
(family with sequence similarity 57, member B), a novel peroxisome
proliferator-activated receptor γ target gene that regulates
adipogenesis through ceramide synthesis. J Biol Chem.
288:4522–4537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin
M, Ma X, Zhou K, Qi J, Yu B and Kou J: Ruscogenin attenuates
cerebral ischemia-induced blood-brain barrier dysfunction by
suppressing TXNIP/NLRP3 inflammasome activation and the MAPK
pathway. Int J Mol Sci. 17:E14182016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gentil BJ, Minotti S, Beange M, Baloh RH,
Julien JP and Durham HD: Normal role of the low-molecular-weight
neurofilament protein in mitochondrial dynamics and disruption in
charcot-marie-tooth disease. FASEB J. 26:1194–1203. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma X, Zhang H, Pan Q, Zhao Y, Chen J, Zhao
B and Chen Y: Hypoxia/aglycemia-induced endothelial barrier
dysfunction and tight junction protein downregulation can be
ameliorated by citicoline. PLoS One. 8:e826042013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li YN, Pan R, Qin XJ, Yang WL, Qi Z, Liu W
and Liu KJ: Ischemic neurons activate astrocytes to disrupt
endothelial barrier via increasing VEGF expression. J Neurochem.
129:120–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hussain AR, Ahmed SO, Ahmed M, Khan OS, Al
Abdulmohsen S, Platanias LC, Al-Kuraya KS and Uddin S: Cross-talk
between NF-κB and the PI3-kinase/AKT pathway can be targeted in
primary effusion lymphoma (PEL) cell lines for efficient apoptosis.
PLoS One. 7:e399452012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin KJ, Deng Z, Hamblin M, Xiang Y, Huang
H, Zhang J, Jiang X, Wang Y and Chen YE: Peroxisome
proliferator-activated receptor delta regulation of miR-15a in
ischemia-induced cerebral vascular endothelial injury. J Neurosci.
30:6398–6408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arsenijevic D, de Bilbao F, Plamondon J,
Paradis E, Vallet P, Richard D, Langhans W and Giannakopoulos P:
Increased infarct size and lack of hyperphagic response after focal
cerebral ischemia in peroxisome proliferator-activated receptor
beta-deficient mice. J Cereb Blood Flow Metab. 26:433–445. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Wang T, Yang K, Xu J, Ren L, Li W
and Liu W: Cerebral microvascular endothelial cell apoptosis after
ischemia: Role of enolase-phosphatase 1 activation and
aci-reductone dioxygenase 1 translocation. Front Mol Neurosci.
9:792016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun H, Xiong W, Arrick DM and Mayhan WG:
Low-dose alcohol consumption protects against transient focal
cerebral ischemia in mice: Possible role of PPARγ. PLoS One.
7:e417162012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng Y, Xiong D, Yin C, Liu B, Shi J and
Gong Q: Icariside II protects against cerebral ischemia-reperfusion
injury in rats via nuclear factor-κB inhibition and peroxisome
proliferator-activated receptor up-regulation. Neurochem Int.
96:56–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Green DE, Sutliff RL and Hart CM: Is
peroxisome proliferator-activated receptor gamma (PPARγ) a
therapeutic target for the treatment of pulmonary hypertension?
Pulm Circ. 1:33–47. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mysiorek C, Culot M, Dehouck L, Derudas B,
Staels B, Bordet R, Cecchelli R, Fenart L and Berezowski V:
Peroxisome-proliferator-activated receptor-alpha activation
protects brain capillary endothelial cells from oxygen-glucose
deprivation-induced hyperpermeability in the blood-brain barrier.
Curr Neurovasc Res. 6:181–193. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen YC, Wu JS, Tsai HD, Huang CY, Chen
JJ, Sun GY and Lin TN: Peroxisome proliferator-activated receptor
gamma (PPAR-γ) and neurodegenerative disorders. Mol Neurobiol.
46:114–124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng Y, Xie K, Dong H, Zhang H, Wang F, Li
Y and Xiong L: Hyperbaric oxygen preconditioning protects cortical
neurons against oxygen-glucose deprivation injury: Role of
peroxisome proliferator-activated receptor-gamma. Brain Res.
1452:140–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gupta D, Jetton TL, Mortensen RM, Duan SZ,
Peshavaria M and Leahy JL: In vivo and in vitro studies of a
functional peroxisome proliferator-activated receptor gamma
response element in the mouse pdx-1 promoter. J Biol Chem.
283:32462–32470. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He F, Qu F and Song F: Aspirin upregulates
the expression of neuregulin 1 and survivin after focal cerebral
ischemia/reperfusion in rats. Exp Ther Med. 3:613–616. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu ZJ, Liu HQ, Xiao C, Fan HZ, Huang Q,
Liu YH and Wang Y: Curcumin protects neurons against oxygen-glucose
deprivation/reoxygenation-induced injury through activation of
peroxisome proliferator-activated receptor-γ function. J Neurosci
Res. 92:1549–1559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu N, Zhang Y, Fan L, Yuan M, Du H, Cheng
R, Liu D and Lin F: Effects of transplantation with bone
marrow-derived mesenchymal stem cells modified by Survivin on
experimental stroke in rats. J Transl Med. 9:1052011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fiatte C, Huin C, Collet P, Plenat F,
Dauca M and Schohn H: Expression of PPARgamma is reduced by medium
supplementation with L-glutamine in human colorectal Caco-2 cells.
Int J Mol Med. 22:825–832. 2008.PubMed/NCBI
|
|
36
|
Hamy AS, Bieche I, Lehmann-Che J, Scott V,
Bertheau P, Guinebretiere JM, Matthieu MC, Sigal-Zafrani B, Tembo
O, Marty M, et al: BIRC5 (survivin): A pejorative prognostic marker
in stage II/III breast cancer with no response to neoadjuvant
chemotherapy. Breast Cancer Res Treat. 159:499–511. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lamers F, Van der Ploeg I, Schild L, Ebus
ME, Koster J, Hansen BR, Koch T, Versteeg R, Caron HN and Molenaar
JJ: Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma
via mitotic catastrophe. Endocr Relat Cancer. 18:657–668. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li PL, Zhang X, Wang LL, Du LT, Yang YM,
Li J and Wang CX: MicroRNA-218 is a prognostic indicator in
colorectal cancer and enhances 5-fluorouracil-induced apoptosis by
targeting BIRC5. Carcinogenesis. 36:1484–1493. 2015.PubMed/NCBI
|
|
39
|
Wang H, Zhang X, Wang L, Zheng G, Du L,
Yang Y, Dong Z, Liu Y, Qu A and Wang C: Investigation of cell free
BIRC5 mRNA as a serum diagnostic and prognostic biomarker for
colorectal cancer. J Surg Oncol. 109:574–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Q, Shu R, He H, Wang L, Ma Y, Zhu H,
Wang Z, Wang S, Shen G and Lei P: Co-silencing of Birc5 (survivin)
and Hspa5 (Grp78) induces apoptosis in hepatoma cells more
efficiently than single gene interference. Int J Oncol. 41:652–660.
2012. View Article : Google Scholar : PubMed/NCBI
|
